Exploring a Novel Approach Using a Glyco-Immune Therapy Targeting Both Complement and Macrophages

Time: 12:00 pm
day: Day Two


  • A discussion of how macrophages/microglia are involved in the pathobiology of AMD
  • What are Siglecs and self-associated molecular patterns and how do they modulate immune responses?
  • A novel glyco-engineered nanoparticle that inhibits over-activation of complement and macrophages